| |
|
|
| 9:15 AM |
|
Welcome and Introduction of Speaker
Arthur Stokes, M.D.
Wistar Board of Trustees |
| 9:30 AM |
|
Admixture mapping identifies 8q24
as a prostate cancer risk focus in
African-American men
Matthew Freedman, M.D.
Dana-Farber Cancer Institute
*FOR SCIENTISTS AND PHYSICIANS ONLY |
| 10:30 AM |
|
Registration and Continental Breakfast
Atrium |
| 11:00 AM |
|
Press Conference |
| 11:00 AM |
|
Battling the Killer Within and Winning
Thomas Farrington
Founder, Prostate Health Education Network
Hilary Koprowski, M.D., Conference Room |
| 12:00 PM |
|
Buffet Lunch
Atrium |
| 1:00 PM |
|
Welcome
Russel E. Kaufman, M.D.
President & CEO, The Wistar Institute
Jerry Johnson
Chairman & CEO, Radnor Trust Company |
| 1:15 PM |
|
Research & Treatment panel discussion
Gordon L. Grado, M.D.
Founder, Southwest Oncology
Centers and the Grado Radiation
Center of Excellence
Scottsdale, AZ
David I. Lee, M.D.
Chief, Division of Urology
Penn Presbyterian Medical Center
Philadelphia, PA
Matthew Freedman, M.D.
Medical Oncology, Cancer Genomics
Dana-Farber Cancer Institute
Boston, MA Moderator: Russel E. Kaufman, M.D. |
| 2:30 pm |
|
Break
Atrium |
| 2:45 pm |
|
Break Out Sessions
Gordon L. Grado, M.D.
Founder, Southwest Oncology
Centers and the Grado Radiation
Center of Excellence
Scottsdale, AZ
David I. Lee, M.D.
Chief, Division of Urology
Penn Presbyterian Medical Center
Philadelphia, PA
Matthew Freedman, M.D.
Medical Oncology, Cancer Genomics
Dana-Farber Cancer Institute
Boston, MA
David W. Speicher, Ph.D.
Professor and Program Co-Leader
Molecular and Cellular Oncogenesis Program
The Wistar Institute, Philadelphia, PA |
| 4:00 pm |
|
Wrap Up |
| 4:30 pm |
|
Reception
Atrium |
| |
|
|
